BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 24798891)

  • 21. Emergency Department Visits for Adverse Drug Reactions Involving Alcohol: United States, 2005 to 2011.
    Castle IJ; Dong C; Haughwout SP; White AM
    Alcohol Clin Exp Res; 2016 Sep; 40(9):1913-25. PubMed ID: 27488763
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adverse drug reactions in patients with Alzheimer's disease and related dementia in France: a national multicentre cross-sectional study.
    Laroche ML; Perault-Pochat MC; Ingrand I; Merle L; Kreft-Jais C; Castot-Villepelet A; Durrieu G; Gras V; Guy C; Jean-Pastor MJ; Jonville-Béra AP; Merlet-Chicoine I; Miremont-Salamé G; Nourhashemi F; Charmes JP;
    Pharmacoepidemiol Drug Saf; 2013 Sep; 22(9):952-60. PubMed ID: 23794320
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hospital re-admission associated with adverse drug reactions in patients over the age of 65 years.
    Hauviller L; Eyvrard F; Garnault V; Rousseau V; Molinier L; Montastruc JL; Bagheri H
    Eur J Clin Pharmacol; 2016 May; 72(5):631-9. PubMed ID: 26884320
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Frequency and severity of adverse drug reactions due to self-medication: a cross-sectional multicentre survey in emergency departments.
    Asseray N; Ballereau F; Trombert-Paviot B; Bouget J; Foucher N; Renaud B; Roulet L; Kierzek G; Armand-Perroux A; Potel G; Schmidt J; Carpentier F; Queneau P
    Drug Saf; 2013 Dec; 36(12):1159-68. PubMed ID: 24163273
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adverse Drug Reaction (ADR) as a Cause of Hospitalization at a Government Hospital in Saudi Arabia: A Prospective Observational Study.
    Alayed N; Alkhalifah B; Alharbi M; Alwohaibi N; Farooqui M
    Curr Drug Saf; 2019; 14(3):192-198. PubMed ID: 31109277
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
    Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
    Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [SAMU (Service d'Aide Médicale Urgente) in France].
    Martinez-Almoyna M
    Masui; 1988 Feb; 37(2):138-46. PubMed ID: 3373724
    [No Abstract]   [Full Text] [Related]  

  • 28. A systematic review of the prevalence and risk factors for adverse drug reactions in the elderly in the acute care setting.
    Alhawassi TM; Krass I; Bajorek BV; Pont LG
    Clin Interv Aging; 2014; 9():2079-86. PubMed ID: 25489239
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adverse drug reaction-related hospitalisations: a nationwide study in The Netherlands.
    van der Hooft CS; Sturkenboom MC; van Grootheest K; Kingma HJ; Stricker BH
    Drug Saf; 2006; 29(2):161-8. PubMed ID: 16454543
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of serious adverse drug reactions as cause of emergency department visit in children: a 5-years active pharmacovigilance study.
    Lombardi N; Crescioli G; Bettiol A; Marconi E; Vitiello A; Bonaiuti R; Calvani AM; Masi S; Lucenteforte E; Mugelli A; Giovannelli L; Vannacci A
    BMC Pharmacol Toxicol; 2018 Apr; 19(1):16. PubMed ID: 29661234
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Results of 1885 inter-hospital evacuations accomplished by the Toulouse SAMU (Service d'Aide Medicale Urgente--Emergency Medical Service)].
    Virenque C
    Nouv Presse Med; 1975 Jan; 4(3):197-200. PubMed ID: 1129085
    [No Abstract]   [Full Text] [Related]  

  • 32. Consequences, measurement, and evaluation of the costs associated with adverse drug reactions among hospitalized patients in China.
    Qing-ping S; Xiao-dong J; Feng D; Yan L; Mei-ling Y; Jin-xiu Z; Shu-qiang Z
    BMC Health Serv Res; 2014 Feb; 14():73. PubMed ID: 24533894
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Paradoxical adverse drug reactions: descriptive analysis of French reports.
    Hakimi Y; Petitpain N; Pinzani V; Montastruc JL; Bagheri H
    Eur J Clin Pharmacol; 2020 Aug; 76(8):1169-1174. PubMed ID: 32418024
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neonatal adverse drug reactions: an analysis of reports to the French pharmacovigilance database.
    Kaguelidou F; Beau-Salinas F; Jonville-Bera AP; Jacqz-Aigrain E
    Br J Clin Pharmacol; 2016 Oct; 82(4):1058-68. PubMed ID: 27276109
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Online reporting of adverse drug reactions: a study from a French regional pharmacovigilance center.
    Abadie D; Chebane L; Bert M; Durrieu G; Montastruc JL
    Therapie; 2014; 69(5):395-400. PubMed ID: 25269141
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence, risk factors and main features of adverse drug reactions leading to hospital admission.
    Pedrós C; Quintana B; Rebolledo M; Porta N; Vallano A; Arnau JM
    Eur J Clin Pharmacol; 2014 Mar; 70(3):361-7. PubMed ID: 24362489
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mortality from adverse drug reaction-related hospitalizations in south-west Ethiopia: A cross-sectional study.
    Angamo MT; Chalmers L; Curtain CM; Yilma D; Bereznicki L
    J Clin Pharm Ther; 2018 Dec; 43(6):790-798. PubMed ID: 29722039
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Emergency department visits caused by adverse drug events: results of a French survey.
    Queneau P; Bannwarth B; Carpentier F; Guliana JM; Bouget J; Trombert B; Leverve X; Lapostolle F; Borron SW; Adnet F;
    Drug Saf; 2007; 30(1):81-8. PubMed ID: 17194173
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Retrospective analysis of adverse drug reactions leading to short-term emergency hospital readmission.
    Banholzer S; Dunkelmann L; Haschke M; Derungs A; Exadaktylos A; Krähenbühl S; Liakoni E
    Swiss Med Wkly; 2021 Jan; 151():w20400. PubMed ID: 33516159
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The general practitioner's knowledge and attitude towards proton pump inhibitors adverse effects].
    Rudelle K; Laroche ML
    Therapie; 2020; 75(3):253-260. PubMed ID: 31471066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.